Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
Retiring with $300,000 doesn’t have to mean financial stress. This guide lays out realistic budgets, withdrawal strat...
After a two-week export-control standoff, Anthropic’s most powerful AI models are back online. The settlement restore...
Jim Cramer challenges a fresh downgrade on Apple, arguing the stock’s AI ambitions and a possible 2027 supercycle jus...
Netflix is tightening access to viewing data as it trims public reporting on audience insights, prompting a cautious ...
Lawmakers warn that granting a national bank charter to a crypto-focused issuer could undermine financial integrity a...
MSFO continues to pay weekly distributions despite a sharp stock slide in Microsoft. As MSFT falls, MSFO investors we...
Arbor Homes launches its Arrival Series in Louisville, debuting homes from $199,995 to tackle rising housing costs. T...
Unlock a practical, step-by-step blueprint for financial freedom through turnkey rentals. Learn how to estimate cash ...
The short-term rental landscape has shifted dramatically. This guide explains how Airbnb evolved—here’s investors sho...
A high dividend can spark doubt. This article breaks down pfizer's 6.5% dividend yield, what it signals about the bus...